Long non-coding RNA in glioma: signaling pathways

Jia Shi; Bo Dong; Jiachao Cao; Yumin Mao; Wei Guan; Ya Peng; Suinuan Wang

doi:10.18632/oncotarget.15175

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Long non-coding RNA in glioma: signaling pathways

Jia Shi, Bo Dong, Jiachao Cao, Yumin Mao, Wei Guan, Ya Peng and Suinuan Wang _

PDF | HTML | How to cite

Oncotarget. 2017; 8:27582-27592. https://doi.org/10.18632/oncotarget.15175

Metrics: PDF 4938 views | HTML 6355 views | ?

Abstract

Jia Shi1,*, Bo Dong1,*, Jiachao Cao1,*, Yumin Mao1, Wei Guan1, Ya Peng1 and Suinuan Wang1

1 Department of Neurosurgery, The Third Affiliated Hospital of Soochow University, Changzhou, China

* These authors have contributed equally to this work

Correspondence to:

Suinuan Wang, email:

Ya Peng, email:

Keywords: long non-coding RNAs, glioma, microRNA

Received: November 11, 2016 Accepted: January 24, 2017 Published: February 07, 2017

Abstract

Glioma is regarded as the most prevalent malignant carcinoma of the central nervous system. Thus, the development of new therapeutic strategies targeting glioma is of significant clinical importance. Long non-coding RNAs (lncRNAs) are functional RNA molecules without a protein-coding function and are reportedly involved in the initiation and progression of glioma. Dysregulation of lncRNAs in glioma is due to activation of several signaling pathways, such as the BRD4-HOTAIR-β-catenin/PDCD4, p53-Hif-H19/IGF2 and CRNDE/mTOR pathways. Furthermore, microRNAs (miRNAs) such as miR-675 also interact with lncRNAs in glioma. Thus, exploring the mechanisms by which lncRNA control processes will be instrumental for devising new effective therapies against glioma.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 15175

Publication Alerts

Post-Publication Promotion

Publication Discount

Reviews:

Long non-coding RNA in glioma: signaling pathways

Abstract